Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C. and Polsinelli P.C. have advised Saltair. Ropes & Gray LLP has advised TSG Consumer. Saltair, an award-winning body...
Saltair Sells Majority Stake to TSG Consumer
Edesa Biotech Closes $25 Million Public Offering of Shares and Warrants
Lowenstein Sandler LLP acted as US counsel Edesa Biotech, Inc., Fasken Martineau DuMoulin, LLP, Canadian local counsel for the Company, Fenwick & West LLP, intellectual property...
LB Pharmaceuticals Completes $150 Million Private Placement of Common Stock and Pre-Funded Warrants
Cooley LLP has advised LB Pharmaceuticals Inc. Mintz has advised Leerink Partners and Piper Sandler as placement agents. LB Pharmaceuticals Inc. (Nasdaq: LBRX) has announced the...
uniQure Completes $259 Million Public Offering of Ordinary Shares
Morgan, Lewis & Bockius LLP, NautaDutilh N.V., Van Campen Liem, Nederlandsch Octrooibureau, and Clark & Elbing, LLP have advised uniQure. Mintz has advised the underwriters. uniQure...
CalciMedica Announces Private Placement of Up to $49 Million
Mintz has advised Guggenheim Securities as placement agent on the deal. CalciMedica, Inc., a clinical-stage biopharmaceutical company, has entered into a definitive securities purchase agreement for...
MoonLake Immunotherapeutics Completes $200 Million Public Offering of Class A Shares
Gibson, Dunn & Crutcher LLP and Walkers (Cayman) LLP have advised MoonLake Immunotherapeutics. Mintz has advised the underwriters. MoonLake Immunotherapeutics (NASDAQ: MLTX) has completed a public...
Rallybio to Acquire Avenzo Therapeutics and Complete $215 Million Private Placement
Cooley has advised Avenzo Therapeutics. Ropes & Gray has advised Rallybio Corporation. Mintz has advised the placement agents. Rallybio Corporation has entered into a definitive agreement...
Assembly Biosciences Completes $115 Million Registered Offering of Common Stock and Pre-Funded Warrants
Skadden has advised Assembly Biosciences. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo has advised the underwriters. Assembly Biosciences, Inc. has announced the closing of its underwritten...
Avalo Therapeutics Launches $430 Million Public Offering of Common Stock and Warrants
Goodwin Procter LLP has advised Avalo Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the underwriters. Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a...
InflaRx Prices $150 Million Public Offering of Ordinary Shares
Kirkland & Ellis has advised InflaRx. Mintz has advised the underwriters. InflaRx N.V., a biopharmaceutical company focused on anti-inflammatory therapeutics, has announced the pricing of its...
Obsidian Therapeutics and Galera Therapeutics Announce $350 Million Merger and Private Placement
Goodwin Procter LLP has advised Obsidian Therapeutics. Sidley Austin LLP has advised Galera Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the placement...
SAB Biotherapeutics Completes $85 Million Public Offering
Dentons has advised SAB Biotherapeutics, Inc. Mintz has advised the underwriters. SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin...